Celbridge Science

Qualification-grade evidence for methods that replace animal testing.

For federal programs, consortia, and translational science teams establishing readiness standards for New Approach Methodologies.

What makes this hard

No shared evidentiary bar

Alternative methods lack standardized qualification benchmarks and evidence frameworks that hold across participating laboratories.

Reproducibility across sites is unproven

A method that performs in one lab must demonstrate cross-laboratory reproducibility before it can anchor a regulatory pathway.

Translational readiness is asserted, not scored

Programs need structured readiness assessment before committing qualification resources to a method.

Where we engage

Translational NAMs qualification

Readiness and validation standards for microphysiological systems and organ-on-chip platforms under OECD GD 34.

Evidence standards authoring

Structured, non-compensatory evidence frameworks that participating labs can actually execute against.

Cross-laboratory benchmarking

Comparator design and reproducibility verification across sites, instruments, and reagent batches.

Celbridge serves as a performer on the NIH Common Fund Complement-ARIE program, providing translational readiness assessment within the NAMs Reduction to Practice Challenge.

Framework anchors

OECD GD 34FDA Modernization Act 2.0ISO/IEC 23894NIST AI RMF 1.0

Every engagement is structured in the evidentiary language these frameworks expect — so the work survives reviewer scrutiny, not just internal approval.

Discuss translational readiness for your program.

A briefing on translational readiness scoring and cross-laboratory reproducibility standards for microphysiological systems under OECD GD 34.

or write to [email protected]

Prefer to see the work first? Walk through an eight-week pilot, step by step